Ken Griffin Akoya Biosciences, Inc. Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$1.94 - $4.56 $2,716 - $6,383	-1,400 Reduced 17.5%	6,600 $15,000
Q1 2024 May 15, 2024	SELL	$4.33 - $6.06 $5,196 - $7,271	-1,200 Reduced 13.04%	8,000 $37,000
Q4 2023 Feb 14, 2024	SELL	$3.13 - $5.13 $2,817 - $4,617	-900 Reduced 8.91%	9,200 $44,000
Q3 2023 Nov 14, 2023	SELL	$4.24 - $7.44 $15,264 - $26,784	-3,600 Reduced 26.28%	10,100 $46,000
Q2 2023 Aug 14, 2023	SELL	$5.28 - $8.35 $20,592 - $32,565	-3,900 Reduced 22.16%	13,700 $101,000
Q1 2023 May 15, 2023	BUY	$7.6 - $12.68 $60,800 - $101,440	8,000 Added 83.33%	17,600 $143,000
Q4 2022 Feb 14, 2023	BUY	$8.6 - $14.1 $82,560 - $135,360	9,600 New	9,600 $91,000

12.3M

67.9K

Ticker AKYA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,892,300
Market Cap $90.2M
Description
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.